Eurazeo (RF) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
9 Jul, 2026Executive summary
Fundraising reached €3 billion in the first nine months of 2024, up 76% year-over-year, with strong momentum in private debt (+110%) and private equity (+59%).
Fee-paying AUM increased 12% to €26.0 billion, and total AUM rose 7% to €35.5 billion, with third-party AUM at €25.2 billion.
Realizations surged to €2.4 billion, three times higher than the same period last year, and deployments grew 5% to €3.2 billion.
Portfolio companies delivered robust revenue growth: Buyout +7%, Growth +14%, Real Assets +21%.
Continued progress in ESG and impact, with 33 impact investments and successful fundraising for sustainable infrastructure and biotech funds.
Financial highlights
Third-party management fees increased 15% year-over-year, with total management fees up 9% and performance fees at €12 million.
Institutional fundraising outside France represented 70% of inflows, and wealth management fundraising grew 11% to €629 million.
Net investment portfolio valued at €8.3 billion as of September 30, 2024.
Buyout exits generated an average cash-on-cash multiple of 2.4x, with select venture/growth exits achieving 4.0x.
PME IV (Private Equity) delivered a gross IRR of 33% and a gross MOIC of 1.7x.
Outlook and guidance
Full-year 2024 fundraising is expected to reach around €4 billion, continuing the growth trend from previous years.
Asset rotation expected to exceed 11% of the previous year's portfolio by year-end, though below the typical 20-25% pace.
Management reiterates commitment to 15% average annual growth in third-party management fees through 2027.
Operating leverage anticipated in 2024, balancing cost discipline with growth investments.
Further increase in realization volumes anticipated, supported by a strong exit pipeline.
Latest events from Eurazeo
- €3.2bn raised, AUM up 5%, and strong exits drive 2.1x returns and higher shareholder payouts.RF
Q3 20259 Jul 2026 - All 22 resolutions passed as strong fundraising, a 10% dividend hike, and strategic progress were reported.RF
AGM 20259 Jul 2026 - Record fundraising and exits drive growth, despite fair value losses; shareholder returns boosted.RF
Q4 20248 Jul 2026 - Q1 2025 fundraising quadrupled, AUM and shareholder returns rose, and portfolio growth was strong.RF
Q1 202524 Jun 2026 - Strong fundraising, AUM growth, and asset rotation boosted financial position and returns.RF
Q1 202613 May 2026 - AGM approved all resolutions amid strong asset management growth and increased dividends.RF
AGM 202612 May 2026 - Record fundraising and AUM growth drove higher margins and strong shareholder returns.RF
Q4 202511 Mar 2026 - Fundraising and realizations surged, driving growth and enhanced shareholder returns.RF
Q2 20243 Feb 2026 - AUM up 4% to €36.8bn, but net loss widened to -€309m amid fair value and currency headwinds.RF
Q2 20258 Aug 2025